Criminal or bystander: imatinib and second primary malignancy in GIST patients

被引：8
|
作者：
Kanda, Tatsuo [1 ]
机构：
[1] Sanjo Gen Hosp, Sanjo City, Niigata 9550055, Japan
来源：
CHINESE JOURNAL OF CANCER RESEARCH | 2013年 / 25卷 / 05期
关键词：
GASTROINTESTINAL STROMAL TUMORS; NEOPLASMS; COEXISTENCE; KIT;
D O I：
10.3978/j.issn.1000-9604.2013.10.15
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：490 / 492
页数：3
相关论文
共 50 条
  • [21] Does a diagnosis of GIST predict a second primary cancer?
    Smith, Myles J. F.
    Mahar, Alyson L.
    Law, Calvin
    Ko, Yoo-Joung
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [22] Imatinib plasma levels: correlation with clinical benefit in GIST patients
    N Widmer
    L A Decosterd
    C Csajka
    M Montemurro
    A Haouala
    S Leyvraz
    T Buclin
    British Journal of Cancer, 2010, 102 : 1198 - 1199
  • [23] Therapeutic drug monitoring of imatinib in GIST patients: a tunisian series
    Meganem, H.
    Trabelsi, S.
    Klouz, A.
    Lakhal, M.
    ANNALS OF ONCOLOGY, 2015, 26
  • [24] Calculating the risk of toxicity for patients with advanced GIST treated with imatinib
    Nature Clinical Practice Oncology, 2006, 3 (11): : 589 - 589
  • [25] Erythropoietin for anemia treatment of patients with GIST receiving imatinib.
    Duffaud, F
    Lecesne, A
    Ray-Coquard, I
    Bompass, E
    Assi, K
    Berthaud, P
    Ducimetiere, F
    Blay, JY
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 829S - 829S
  • [26] Incidence, risk and prognosis of second primary malignancy of patients with gastric adenocarcinoma
    Jin, Liyan
    Su, Xinyue
    Li, Wenjing
    Wu, Jie
    Zhang, Hua
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [27] Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma
    Zhang, Guoqing
    Wu, Bin
    Wang, Xiaofei
    Li, Jindong
    MEDICINE, 2019, 98 (36)
  • [28] Lenalidomide (Revlimid) and second primary malignancy
    不详
    AUSTRALIAN PRESCRIBER, 2012, 35 (05) : 162 - 162
  • [29] Second primary malignancy in patients with cholangiocarcinoma: a population-based study
    Zhuang, Liping
    Yan, Xia
    Meng, Zhiqiang
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 1969 - 1983
  • [30] Risk of second primary malignancy in patients with AL amyloidosis treated with lenalidomide
    Merli, Michele
    Maffioli, Margherita
    Ferrario, Andrea
    Passamonti, Francesco
    AMERICAN JOURNAL OF HEMATOLOGY, 2013, 88 (08) : 719 - 720
12345